Yu Z - Search Results

1

Effectiveness and safety of pyrotinib-based therapy in patients with HER2-positive metastatic breast cancer: A real-world retrospective study.

Li C, Bian X, Liu Z, Wang X, Song X, Zhao W, Liu Y, Yu Z. Li C, et al. Among authors: yu z. Cancer Med. 2021 Dec;10(23):8352-8364. doi: 10.1002/cam4.4335. Epub 2021 Oct 21. Cancer Med. 2021. PMID: 34672424 Free PMC article.

2

[Inhibitory and apoptosis regulating effects of adriamycin on different human breast cancer cell lines].

Yu ZY, Zuo WS, Wei L, Shan PY, Song XR, Liu YT, Liu YS, Zhou ZB, Shao ZM. Yu ZY, et al. Zhonghua Yi Xue Za Zhi. 2005 Jan 5;85(1):19-22. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15808069 Chinese.

3

[Flow cytometric quantitative analysis of multiple tumor suppressor gene 1 (MTS1) and cyclooxygenase-2 (COX-2) gene expressions in invasive breast cancers and their clinical significance].

Zuo WS, Wei L, Wang XW, Wang YS, Yu ZY, Bi Y, Liu YS, Zhou ZB. Zuo WS, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):515-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17147116 Chinese.

4

[Systematic review of validation phase of breast cancer sentinel lymph node biopsy results in China].

Zheng G, Yang J, Zuo WS, Yu ZY, Liu YS, Zheng MZ, Wang SF. Zheng G, et al. Zhonghua Yi Xue Za Zhi. 2011 Feb 15;91(6):361-5. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21418905 Review. Chinese.

5

[Analysis of clinicopathological factors associated with false-negative rate of sentinel lymph node biopsy in breast cancer patients: experience of a single center].

Yang B, Zheng G, Zuo WS, Yang L, Wang YS, Zheng MZ, Liu YS, Yu ZY. Yang B, et al. Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):389-93. doi: 10.3760/cma.j.issn.0253-3766.2013.05.015. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24054019 Chinese.

6

Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib.

Wang X, Song H, Yu Q, Liu Q, Wang L, Liu Z, Yu Z. Wang X, et al. Among authors: yu q, yu z. Oncol Rep. 2015 Feb;33(2):526-32. doi: 10.3892/or.2014.3665. Epub 2014 Dec 11. Oncol Rep. 2015. PMID: 25501339 Free PMC article.

7

[Effect of recombinant human p53 adenovirus (Ad-p53) combined with EGFR inhibitor gefitinib on the sensitivity of breast cancer MDA-MB-468 cells].

Wang X, Guan X, Wang L, Xie L, Liu Q, Yu Z. Wang X, et al. Among authors: yu z. Zhonghua Zhong Liu Za Zhi. 2014 Dec;36(12):886-91. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25623760 Chinese.

8

Effects of the ninein-like protein centrosomal protein on breast cancer cell invasion and migration.

Liu Q, Wang X, Lv M, Mu D, Wang L, Zuo W, Yu Z. Liu Q, et al. Among authors: yu z. Mol Med Rep. 2015 Aug;12(2):1659-64. doi: 10.3892/mmr.2015.3650. Epub 2015 Apr 20. Mol Med Rep. 2015. PMID: 25901761 Free PMC article.

9

Primary or metastatic hepatic carcinoma? A breast cancer patient after adjuvant chemotherapy and radiotherapy postoperatively with intrahepatic cholangiocarcinoma and review of the literature.

Liu ZY, Sun JJ, He KW, Zhuo PY, Yu ZY. Liu ZY, et al. World J Surg Oncol. 2016 Jul 15;14(1):183. doi: 10.1186/s12957-016-0943-0. World J Surg Oncol. 2016. PMID: 27422708 Free PMC article. Review.

10

Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer.

Liu Z, He K, Ma Q, Yu Q, Liu C, Ndege I, Wang X, Yu Z. Liu Z, et al. Among authors: yu q, yu z. PLoS One. 2017 May 22;12(5):e0177694. doi: 10.1371/journal.pone.0177694. eCollection 2017. PLoS One. 2017. PMID: 28531218 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,122 results

Search Page

Filters